Dec 08, 2020
Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund.
Bened Biomedical Grants Exclusive Rights for PS128™ to M8 Pharmaceuticals
top of page
bottom of page
Dec 08, 2020
Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund.